| Name | Cbl-b-IN-8 |
|---|
| Description | Cbl-b-IN-8 (Compound 293) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 5.5 nM and 7.8 nM, respectively[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 5.5 nM (Cbl-b), 7.8 nM (c-Cbl)[1] |
| References |
[1]. Jun Liang, et al. Lactams as cbl-b inhibitors. Patent WO2022169997A1. |
| Molecular Formula | C35H44F3N7O3 |
|---|---|
| Molecular Weight | 667.76 |